Single Shot Infraclavicular Brachial Plexus Block vs Local Infiltration After Wrist Arthroscopy Surgery



Status:Completed
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:2/8/2019
Start Date:September 2016
End Date:October 5, 2018

Use our guide to learn which trials are right for you!

Comparison Between Infraclavicular Brachial Plexus Block Versus Local Infiltration for Postoperative Analgesia After Wrist Arthroscopy, a Prospective Randomized Open Label Study

The purpose of this study is to compare infraclavicular brachial plexus shot single shot
block to local infiltration done in adult patients having wrist arthroscopy surgery. Visual
analogue scores, opioid consumption, quality of recovery and quality of sleep up to 72 hours
post operatively will be used for comparison.

If the patient is willing to participate and signs the consent, he/she will be randomized to
one of the two treatment groups:

1. Single shot block

2. Local Infiltration

In the institution investigators usually advocate for regional anesthesia and intravenous
sedation for the repair of open fracture of the distal radius.

Patients will be monitored during block performance with standard ASA monitors. All patients
will receive 2 L of oxygen via a nasal cannula. Sedatives will be titrated to effect.
Midazolam 1-2 mg, and fentanyl 50-100 mcg will be used for sedation.

Block time out will be preformed according to standard operating procedure. All blocks will
be done under ultrasound guidance. Sonosite S nerve machine will be used with a low frequency
curvilinear (C5) US probe with 2-5 MHZ frequency. Both single shot and local infiltration
will be performed according to the SOP in the department. Ultrasound survey of the
deltopectoral groove below the clavicle will take place. The axillary artery and the three
cords (posterior, medial and lateral) of the brachial plexus will be identified in short axis
view deeper to the pectoralis minor muscle.

For single shot blocks: A 4 inch 21 gauge single shot (B-Braun) needle will be introduced
in-plane towards the posterior cord of the brachial plexus and 1-2 mL of dextrose 5% (D5%)
bolus will be used to verify correct placement of the needle in the vicinity of the posterior
cord and adequate spread pattern to both lateral and medical cord. 20 ml of of Ropivicaine
0.5% will be injected through the needle with intermittent aspiration after each 5 ml bolus
injection.

For local infiltration: At the end of surgery, surgeon will inject 10 ml of Ropivacaine 0.5%
into the arthroscopy portals and the wrist. Specifically, 1 ml to 2 ml of Ropivacaine 0.5%
will be injected into each portal with the remainder of the volume injected into the joint
space itself.

Block success will be defined as a change in cutaneous sensation to touch with an alcohol pad
in the posterior, medial and lateral cord distribution over the forearm and the hand within
30min after injection. Subjects with successful catheter placement per protocol and nerve
block onset will be retained in the study. Subjects with a failed catheter insertion or
misplaced catheter indicated by a lack of sensory changes will have their catheter replaced
or will be single shot blocked and withdrawn from the study.

Intraoperative sedation will consist of intermittent boluses of midazolam (1-2 mg), fentanyl
(50-100 mcg) and propofol infusion, titrates to sedation and patient comfort (25-50
mcg/kg/min).

All patients will receive prophylaxis for postoperative nausea and vomiting (PONV) during
surgery. The protocol for prophylaxis against PONV includes administration of 4 mg of
dexamethasone after induction of anesthesia and 4 mg of ondansetron 20 minutes before
recovery from anesthesia. Dexamethasone is withheld if the patient has poorly controlled
diabetes mellitus (DM). Uncontrolled DM will be defined as random blood glucose above 250
mg/dl.

Inclusion Criteria:

- Patients scheduled for wrist arthroscopy

- American Society of Anesthesiologists (ASA) physical status I -III

- Mentally competent and able to give consent for enrollment in the study

Exclusion Criteria:

- Patient younger than 18 years old

- Allergy to local anesthetics, systemic opioids (fentanyl, morphine, hydromorphone and
any of the drugs included in the standard of care

- Patients opting to go under light anesthesia and those refusing the block

- Chronic pain syndromes; Patients will be defined to have chronic pain if they are
using regular daily doses of systemic narcotics for the past 6 months prior to the
surgery

- BMI of 40 or more
We found this trial at
1
site
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Principal Investigator: Nabil M Elkassabany, MD
Phone: 215-294-9165
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials